Guangdong Hongshi Laser Technology Co., Ltd. (HSG Laser) has failed to complete its initial public offering (IPO), marking a ...

The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.

Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.

This is ESR’s first REIT in China, and comprises three stabilised logistics facilities that have an average occupancy of 90%.

Huachen AI Parking Management Technology Holding Co., Ltd. (HCAI) plans to raise $8 million in an initial public offering (IPO) on the week of February 3rd, IPO Scoop reports. The company plans to ...

Chinese soda maker Dayao is gearing up for a Hong Kong initial public offering as early as the second half of 2025, people ...

Within days of its $4.4 billion IPO on the New York Stock Exchange last June, the Chinese ride-hailing giant Didi Global got ...

Today’s episode discusses the recovery of global tourism, Hopper’s possible IPO, and the impact of Trump’s orders on tourism.

The country’s top pork processor reveals the size and price range of its long-rumored separation from China’s WH Group, but a ...

Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the first sizeable Chinese firm to pursue a listing in the U.S. this year.

Phoenix Asia Holdings faces significant risks, including regulatory risks, customer concentration and uncertainties in the ...

Ascentage Pharma Group Corp. Ltd. has priced the first IPO of the year in the U.S. The offering of 7.32 million shares has the Suzhou, China, and Rockville, Md.-based company looking for gross ...